Skip to main content

Advertisement

SpringerLink
Log in

Sleep Apnea and Cardiovascular Disease

  • Other Forms of Diabetes and Its Complications (B Wojeck and H Yaggi, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Obstructive sleep apnea (OSA) is associated with incident coronary and cerebral vascular disease. The mechanisms underlying this association are thought to include increased sympathetic nervous system activity, oxidative stress, and systemic inflammation, with these effects mediated in part by elevated blood pressure and impaired glucose metabolism. In observational studies, OSA treatment with positive airway pressure (PAP) is associated with a reduction in cardiovascular disease risk. The aim of this review is to evaluate evidence from recent clinical trials that tested the impact of OSA treatment on major cardiovascular disease outcomes.

Recent Findings

Multicenter randomized trials have demonstrated a significant, albeit modest, reduction in blood pressure with OSA treatment. Treatment of OSA has generally not demonstrated improvement in type 2 diabetes mellitus, although limited evidence suggests that treatment may be effective in the prediabetic period. However, recent randomized trials of PAP treatment for OSA failed to demonstrate a reduction in incident or recurrent cardiovascular disease events. This may reflect the enrollment of a mostly non-sleepy study sample, as recent evidence suggests that sleepiness is a predictor of adverse cardiovascular outcomes from OSA.

Summary

PAP treatment of OSA lowers blood pressure and may improve glucose metabolism; however, randomized clinical trials do not indicate a reduction in cardiovascular risk with treatment of minimally symptomatic OSA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996;109:659–63. https://doi.org/10.1378/chest.109.3.659.

    Article  CAS  PubMed  Google Scholar 

  2. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med. 1996;101:251–6. https://doi.org/10.1016/S0002-9343(96)00122-2.

    Article  CAS  PubMed  Google Scholar 

  3. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 1999;14:179–84. https://doi.org/10.1034/j.1399-3003.1999.14a30.x.

    Article  CAS  PubMed  Google Scholar 

  4. Garcia-Rio F, Alonso-Fernández A, Armada E, Mediano O, Lores V, Rojo B, et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol. 2013;168:1328–35. https://doi.org/10.1016/j.ijcard.2012.12.015.

    Article  PubMed  Google Scholar 

  5. Mooe T, Franklin KA, Holmström K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164:1910–3. https://doi.org/10.1164/ajrccm.164.10.2101072.

    Article  CAS  PubMed  Google Scholar 

  6. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166:159–65. https://doi.org/10.1164/rccm.2105124.

    Article  PubMed  Google Scholar 

  7. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–53. https://doi.org/10.1016/S0140-6736(05)71141-7.

    Article  PubMed  Google Scholar 

  8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41. https://doi.org/10.1056/NEJMoa043104.

    Article  CAS  PubMed  Google Scholar 

  9. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation. 2008;118:955–60. https://doi.org/10.1161/CIRCULATIONAHA.108.783290.

    Article  PubMed  Google Scholar 

  10. Shah NA, Yaggi HK, Concato J, Mohsenin V. Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath. 2010;14:131–6. https://doi.org/10.1007/s11325-009-0298-7.

    Article  PubMed  Google Scholar 

  11. Catalan-Serra P, Campos-Rodriguez F, Reyes-Nuñez N, Selma-Ferrer MJ, Navarro-Soriano C, Ballester-Canelles M, et al. Increased Incidence of stroke, but not coronary heart disease, in elderly patients with sleep apnea. Stroke. 2019;50:491–4. https://doi.org/10.1161/STROKEAHA.118.023353.

    Article  PubMed  Google Scholar 

  12. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med. 2003;254:32–44. https://doi.org/10.1046/j.1365-2796.2003.01177.x.

    Article  CAS  PubMed  Google Scholar 

  13. Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, Soler-Cataluña JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest. 2005;128:2123–9. https://doi.org/10.1378/chest.128.4.2123.

    Article  PubMed  Google Scholar 

  14. Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, Caballero-Martinez I, Catalan-Serra P, Almeida-Gonzalez CV. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med. 2014;189:1544–50. https://doi.org/10.1164/rccm.201311-2012OC.

    Article  PubMed  Google Scholar 

  15. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005;366(9502):2005–11. https://doi.org/10.1016/S0140-6736(05)67760-4.

    Article  CAS  PubMed  Google Scholar 

  16. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. https://doi.org/10.1136/bmj.38875.675486.55.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008:118:1080–111. doi: https://doi.org/10.1161/CIRCULATIONAHA.107.189375.

  18. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep. 1987;10:35–44. https://doi.org/10.1093/sleep/10.1.35.

    Article  CAS  PubMed  Google Scholar 

  19. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–904. https://doi.org/10.1172/JCI118235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fletcher EC, Lesske J, Culman J, Miller CC, Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension. 1992;20:612–9. https://doi.org/10.1161/01.hyp.20.5.612.

    Article  CAS  PubMed  Google Scholar 

  21. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension. 1992;19:555–61. https://doi.org/10.1161/01.hyp.19.6.555.

    Article  CAS  PubMed  Google Scholar 

  22. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997;99:106–9. https://doi.org/10.1172/JCI119120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL, et al. Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol. 1985;2000(88):1093–102. https://doi.org/10.1152/jappl.2000.88.3.1093.

    Article  Google Scholar 

  24. Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010;341:c5991. https://doi.org/10.1136/bmj.c5991.

    Article  PubMed  Google Scholar 

  25. Barbé F, Durán-Cantolla J, Capote F, de la Peña M, Chiner E, Masa JF, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718–26. https://doi.org/10.1164/rccm.200901-0050OC.

    Article  PubMed  Google Scholar 

  26. Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370:2276–85. https://doi.org/10.1056/NEJMoa1306766.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013:310:2407–15. doi: https://doi.org/10.1001/jama.2013.281250.

  28. Feldstein CA. Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials. Clin Exp Hypertens. 2016;38:337–46. https://doi.org/10.3109/10641963.2016.1148156.

    Article  CAS  PubMed  Google Scholar 

  29. Schwarz EI, Schlatzer C, Rossi VA, Stradling JR, Kohler M. Effect of CPAP withdrawal on BP in OSA: data from three randomized controlled trials. Chest. 2016;150:1202–10. https://doi.org/10.1016/j.chest.2016.07.012.

    Article  PubMed  Google Scholar 

  30. Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state of the art review. Chest. 2017;152:1070–86. https://doi.org/10.1016/j.chest.2017.05.009.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J. 2009;50:289–306. https://doi.org/10.1093/ilar.50.3.289.

    Article  CAS  PubMed  Google Scholar 

  32. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 1985;2009(106):1538–44. https://doi.org/10.1152/japplphysiol.91523.2008.

    Article  CAS  Google Scholar 

  33. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137:95–101. https://doi.org/10.1378/chest.09-0791.

    Article  CAS  PubMed  Google Scholar 

  34. Shaw JE, Punjabi NM, Naughton MT, Willes L, Bergenstal RM, Cistulli PA, et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med. 2016;194:486–92. https://doi.org/10.1164/rccm.201511-2260OC.

    Article  CAS  PubMed  Google Scholar 

  35. Polak J, Shimoda LA, Drager LF, Undem C, McHugh H, Polotsky VY, et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep. 2013;36(1483–90):1490A-1490B. https://doi.org/10.5665/sleep.3040.

    Article  Google Scholar 

  36. Lam JC, Lam B, Yao TJ, Lai AY, Ooi CG, Tam S, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010;35:138–45. https://doi.org/10.1183/09031936.00047709.

    Article  CAS  PubMed  Google Scholar 

  37. Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35:617–25. https://doi.org/10.5665/sleep.1816.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Pamidi S, Wroblewski K, Stepien M, Sharif-Sidi K, Kilkus J, Whitmore H, et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med. 2015;192:96–105. https://doi.org/10.1164/rccm.201408-1564OC.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161–8. https://doi.org/10.1001/jama.2012.4366.

    Article  PubMed  Google Scholar 

  40. Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194:613–20. https://doi.org/10.1164/rccm.201601-0088OC.

    Article  CAS  PubMed  Google Scholar 

  41. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919–31. https://doi.org/10.1056/NEJMoa1606599.

    Article  PubMed  Google Scholar 

  42. Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, Abad J, Duran-Cantolla J, Cabriada V, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020;8:359–67. https://doi.org/10.1016/S2213-2600(19)30271-1.

    Article  PubMed  Google Scholar 

  43. Mazzotti DR, Keenan BT, Lim DC, Gottlieb DJ, Kim J, Pack AI. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med. 2019;200:493–506. https://doi.org/10.1164/rccm.201808-1509OC.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Labarca G, Dreyse J, Salas C, Letelier F, Jorquera J. A validation study of four different cluster analyses of obstructive sleep apnea and the incidence of cardiovascular mortality in an Hispanic population. Chest. 2021;S0012–3692(21):01277. https://doi.org/10.1016/j.chest.2021.06.047.

    Article  Google Scholar 

  45. Xie J, Sert Kuniyoshi FH, Covassin N, Singh P, Gami AS, Chahal CAA, et al. Excessive daytime sleepiness independently predicts increased cardiovascular risk after myocardial infarction. J Am Heart Assoc. 2018;7:e007221. https://doi.org/10.1161/JAHA.117.007221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA Boston Healthcare System, 1400 VFW Parkway (111PI), West Roxbury, MA, 02132, USA

    Daniel J. Gottlieb

  2. Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women’s Hospital, Boston, MA, USA

    Daniel J. Gottlieb

  3. Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA

    Daniel J. Gottlieb

Authors
  1. Daniel J. Gottlieb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel J. Gottlieb.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Other Forms of Diabetes and Its Complications

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gottlieb, D.J. Sleep Apnea and Cardiovascular Disease. Curr Diab Rep 21, 64 (2021). https://doi.org/10.1007/s11892-021-01426-z

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11892-021-01426-z

Keywords

Search

Navigation